JP2024510215A5 - - Google Patents

Info

Publication number
JP2024510215A5
JP2024510215A5 JP2023555565A JP2023555565A JP2024510215A5 JP 2024510215 A5 JP2024510215 A5 JP 2024510215A5 JP 2023555565 A JP2023555565 A JP 2023555565A JP 2023555565 A JP2023555565 A JP 2023555565A JP 2024510215 A5 JP2024510215 A5 JP 2024510215A5
Authority
JP
Japan
Application number
JP2023555565A
Other languages
Japanese (ja)
Other versions
JP2024510215A (ja
JPWO2022192694A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/019984 external-priority patent/WO2022192694A1/en
Publication of JP2024510215A publication Critical patent/JP2024510215A/ja
Publication of JP2024510215A5 publication Critical patent/JP2024510215A5/ja
Publication of JPWO2022192694A5 publication Critical patent/JPWO2022192694A5/ja
Pending legal-status Critical Current

Links

JP2023555565A 2021-03-12 2022-03-11 タンパク質発現のための系及び方法 Pending JP2024510215A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163160672P 2021-03-12 2021-03-12
US63/160,672 2021-03-12
PCT/US2022/019984 WO2022192694A1 (en) 2021-03-12 2022-03-11 Systems and methods for protein expression

Publications (3)

Publication Number Publication Date
JP2024510215A JP2024510215A (ja) 2024-03-06
JP2024510215A5 true JP2024510215A5 (https=) 2025-03-19
JPWO2022192694A5 JPWO2022192694A5 (https=) 2025-03-19

Family

ID=83228345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555565A Pending JP2024510215A (ja) 2021-03-12 2022-03-11 タンパク質発現のための系及び方法

Country Status (11)

Country Link
US (1) US20240141373A1 (https=)
EP (1) EP4305176A4 (https=)
JP (1) JP2024510215A (https=)
KR (1) KR20230169989A (https=)
CN (1) CN117321209A (https=)
AU (1) AU2022235284A1 (https=)
BR (1) BR112023018404A2 (https=)
CA (1) CA3211755A1 (https=)
IL (1) IL305817A (https=)
MX (1) MX2023010658A (https=)
WO (1) WO2022192694A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3153942A1 (en) * 2019-09-16 2021-03-25 Excepgen Inc. Systems and methods for protein expression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741022B2 (en) * 2006-01-18 2010-06-22 Wisconsin Alumi Research Foundation Protein inhibitor of Ran activity and methods of use thereof
KR20140071452A (ko) * 2006-04-05 2014-06-11 애브비 바이오테크놀로지 리미티드 항체 정제
AU2007241622A1 (en) * 2006-04-24 2007-11-01 Academisch Medisch Centrum Improved treatment of cystic fibrosis
CN104114572A (zh) * 2011-12-16 2014-10-22 现代治疗公司 经修饰的核苷、核苷酸和核酸组合物
US12590321B2 (en) * 2016-03-19 2026-03-31 Exuma Biotech Corp. Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof
FR3081169B1 (fr) * 2018-05-15 2020-06-19 Messenger Biopharma Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5'
KR20220012231A (ko) * 2019-04-24 2022-02-03 리젠엑스바이오 인크. 완전-인간 번역 후 변형된 항체 치료제
CA3153942A1 (en) * 2019-09-16 2021-03-25 Excepgen Inc. Systems and methods for protein expression

Similar Documents

Publication Publication Date Title
JP2024534216A5 (https=)
JP2025505576A5 (https=)
CL2025003023A1 (es) Motor hidráulico
CL2025002518A1 (es) Composiciones de lactoferrina purificada y métodos de uso.
BR102023009641A2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13168U (https=)
CN307049682S (https=)
CN307047094S (https=)
CN307046609S (https=)
CN307045541S (https=)
CN307045453S (https=)
CN307044619S (https=)
CN307048028S (https=)
CN307049377S (https=)
BY23963C1 (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13176U (https=)
CN307049553S (https=)